Infection Prevention and Control Conference
“The NHS, governments and industry all have key role to play in combating antimicrobial resistance which poses a catastrophic global threat.” - Professor Dame Sally Davies, Chief Medical Officer for England
In May 2016, doctors in the United States reported an infection capable of resisting colistin, the anti-biotic of last resort. Experts predict that if current trends continue, 10 million people globally will die every year from anti-biotic resistant infections.
In the Review on Antimicrobial Resistance, Lord Jim O'Neill called for an anti-biotics revolution both in terms of developing new medicines and reducing the number of prescriptions. GPs in England have been praised for reducing the number of antibiotics given to patients by cutting prescriptions by 2.6 million in 2015/16. But more work needs to be done. Despite ever more rigorous infection prevention measures, NHS England recorded 1,477 MRSA bloodstream infections among hospital patients over the same period.
Join us for the Infection Prevention and Control Conference where leading experts will discuss the latest approaches to controlling and reducing the spread of dangerous infections. Learn how to mitigate against the threat of superbugs such as MRSA, what positive impact new technologies can have and how to effectively manage the use of anti-biotics.
Please register interest below and we will keep you updated
- Benefit from insights into the latest developments in infection control and learn how your organisation can prevent the spread of bugs such as MRSA.
- Have your questions answered by leading experts in health policy and infection control.
- Learn from examples of best practice used by leading NHS organisation who have successfully reduced the number of health care acquired infections.
- Network with other delegates from across the healthcare sector and compare different approaches to infection control.
- Discover new technologies and techniques which can help reduce the number of infections.
Registration, Refreshments and Exhibition
Opening Remarks from Chair
Peter Askew, VP Sales, UK and EMEA, RL Solutions
Improving Infection Control
Reducing infections in the NHS
KEYNOTE - Linda Dempster, Head of Infection Prevention and Control for NHS Improvement
Linda held the post of Deputy Director IPC at The Medway NHS Foundation Trust between 2016 and 2014. She then progressed to The NHS Trust Development Authority as Head Of IPC (South of England), before becoming the National Lead for IPC for NHS Improvement in 2017.
Improving quality of care and patient journey through a patient hand hygiene QI programme.
Quality improvement methodology provides a tool for testing a change; however staff engagement is pivotal for sustained transformation in complex social behaviours and associated reduction in HCAIs.
KEYNOTE - Claire Chadwick, IPS Board Member/Deputy Treasurer and Head Nurse - Infection Prevention and Control, Pennine Acute NHS Trust: Northern Care Alliance
Experience in leading Infection prevention and control services for 23 years within Greater Manchester and currently Head of Infection Prevention Services at Pennine Acute NHS Trust.
National work has included DoH working party for HBN 00 09 Infection Control in the Built Environment and National working party for Guidelines for the Control of VRE.
Currently Deputy Treasurer and member of the Board of the Infection Prevention Society.
Refreshments & Networking and Exhibition
A Global and Scottish perspective on antimicrobial stewardship
KEYNOTE - Dilip Nathwani OBE, Co-Director Academic Health Sciences Partnership in Tayside, Consultant Physician and Honorary Professor of Infection, University of Dundee
Dilip qualified from Aberdeen University in 1984, and has subsequently training in internal medicine/infection/tropical medicine in Aberdeen, Glasgow and Birmingham, UK. Since 2014 he is the Co-Director of the AHSP in Tayside, the first of its kind in Scotland and with the primary aim of enabling innovation across the health and social care sector. He also has been the recent [2008-2017] Chairman of Scottish Government Funded Scottish Antimicrobial Prescribing Group (SAPG). SAPG is a national clinical antimicrobial stewardship programme. Chair of the European Study Group on Antibiotic Policies [ESGAP] from 2011–14 and President of the British Society for Antimicrobial Chemotherapy [BSAC]; Recent National Specialty Adviser for Infectious Diseases to the Scottish Government Health Department; External advisor on Antimicrobial Stewardship & Education Policy to a number of professional societies, governments and non-UK governmental bodies including WHO; Programme director of the first Massive open on line course [MOOC] on Antimicrobial stewardship. In 2015 he was awarded the Order of the British Empire [OBE] by Her Majesty the Queen for outstanding services to the treatment of Infectious Diseases
Dilip has authored more than 250 peer reviewed publications and has a range of local, national and international contributions to research & innovation in the domains of education, quality improvement, guidelines and policy, particularly in the field of antimicrobial stewardship. He also has been interested in outcomes research and value based healthcare.
Is Your Hospital’s Drainage a Contributory Factor in Infection Rates?
Hospitals have seen a rise in infection rates over the past two decades. It is not a coincidence that changes to drainage practices in hospitals directly overlap the same time frame.
Meg Stone, MD, Dyteqta
Meg joined Dyteqta in September 2014. She has over 18 years’ experience and regularly gives presentations at exclusive events focused on infection prevention and improving drainage. Meg holds a BA (hons) from UCLA and an MBA from UCLA Anderson.
Lunch and Networking and Exhibition
A National Collaborative approach to reducing Healthcare Associated Infections and Antimicrobial Resistance
A brief overview of the 1000 Lives National HCAI / AMR Collaborative which was launched in October 2017.
Helen Ronchetti, 1000 Lives HCAI & AMR Programme Manager, 1000 Lives, Public Health Wales
Helen Ronchetti has recently started a secondment to 1000 Lives Improvement. A nurse with over 20 years’ experience of working in a variety of clinical settings, specialising in critical care and infection prevention.
1000 Lives Improvement is the national improvement service for NHS Wales delivered by Public Health Wales. Our aim is to support the NHS to improve outcomes for people using services in Wales. We are integrated into the work of every health board and trust in Wales, supporting national and local improvement programmes across primary, community and acute care. Our reach doesn’t end there - Welsh universities, voluntary organisations, charities and public sector organisations are all involved in our work.
Automated Surveillance – How to strengthen your IPC program
Can effective use of software add value to the work of IPC teams and help improve patient outcomes?
Peter Askew, VP Sales, UK and EMEA, RL Solutions
Peter has 25 years IT and Informatics experience, over half of that time involved in providing solutions for Healthcare organisations across a range of countries. Having worked for various international companies including more recently, Microsoft, where, over a 10 year period he held various UK and European roles within the Healthcare business unit. Peter has just completed 10 years as a publicly elected Governor (5 years as Lead Governor) at Blackpool Teaching Hospitals Foundation Trust, providing oversight, governance and support for improved patient care initiatives. Working with the Executive Team on strategy as well as contributing to the Trust’s Health Informatics program. He joined RL Solutions (a Canadian company with 20 years’ experience in patient safety software) in August 2015 to both manage the existing clients across Europe and the Middle East, as well as bring new solutions to the UK Healthcare market.
NICE guidance and standards for effective antimicrobial use
Johanna Hulme, Associate Director – Medicines evidence and advice, National Institute for Health and Care Excellence (NICE)
Johanna Hulme is the Associate Director of Medicines Evidence and Advice in the Medicines and Technologies Programme at NICE. The programme supports the safe and effective use of medicines and provides a comprehensive suite of guidance, advice and support for delivering quality, safety and efficiency in the use of medicines.
A detailed look at the TARGET Antibiotics Toolkit; the resources, the research and future resource developments
An introduction to each TARGET resource. Followed by an overview of the large RCT and main findings. Finishing with the new UTI resources in development.
Leah Ffion Jones, Research Assistant, Public Health England
Leah is a full time Research Assistant at Public Health England’s Primary Care Unit, and has worked on the TARGET programme for over three years, specialising in using psychological theory to develop and evaluate interventions for primary care clinicians and the general public.
Leah has a background in Psychology and is currently studying for a Professional Doctorate in Health Psychology from the University of the West of England.
Closing Remarks from Chair
|Date||Venue||Price from:||Status||Spaces||Book Now||Enquire|
At the end of the conference delegates will:
- Have a full understanding of the threat that antibiotic resistance poses to the NHS and public health in the UK.
- Identify the role different areas of the NHS have to play in preventing and managing the spread of infections.
- Understand how nurses, and other health care professionals working closely with patients, can take a leading role in reducing infections.
- Be fully aware of the latest innovations in technology and how they are improving outcomes in infection prevention.
- Anticipate how the move to community based care will change the approach to infection prevention and the new challenges this will present.
Who should attend?
Delegates attending this Conference will include clinical directors, medical directors, directors of infection prevention and control, HCAI managers, GPs, infection control advisors, specialist nurses, estate and facilities managers, heads of innovation, leads in acute care and heads of patient safety; and will be drawn from central and local government, the NHS, care home providers, emergency services, private hospitals, academia, the private sector and civil society.